Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
文献类型:期刊论文
作者 | Deng, Huan1,4,5,6; Hang, Qingqing1,3,5,6; Shen, Dijian1,5,6; Zhang, Yibi2; Chen, Ming1,4,5,6 |
刊名 | CANCER CELL INTERNATIONAL
![]() |
出版日期 | 2021-05-12 |
卷号 | 21 |
关键词 | Lung adenocarcinoma Weighted gene coexpression network analysis Differential coexpression genes Protein-protein interaction network Survival analysis |
DOI | 10.1186/s12935-021-01933-9 |
通讯作者 | Chen, Ming(chenming@zjcc.org.cn) |
英文摘要 | Purpose: Exploring the molecular mechanisms of lung adenocarcinoma (LUAD) is beneficial for developing new therapeutic strategies and predicting prognosis. This study was performed to select core genes related to LUAD and to analyze their prognostic value. Methods: Microarray datasets from the GEO (GSE75037) and TCGA-LUAD datasets were analyzed to identify differentially coexpressed genes in LUAD using weighted gene coexpression network analysis (WGCNA) and differential gene expression analysis. Functional enrichment analysis was conducted, and a protein-protein interaction (PPI) network was established. Subsequently, hub genes were identified using the CytoHubba plug-in. Overall survival (OS) analyses of hub genes were performed. The Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Human Protein Atlas (THPA) databases were used to validate our findings. Gene set enrichment analysis (GSEA) of survival-related hub genes were conducted. Immunohistochemistry (IHC) was carried out to validate our findings. Results: We identified 486 differentially coexpressed genes. Functional enrichment analysis suggested these genes were primarily enriched in the regulation of epithelial cell proliferation, collagen-containing extracellular matrix, transforming growth factor beta binding, and signaling pathways regulating the pluripotency of stem cells. Ten hub genes were detected using the maximal clique centrality (MCC) algorithm, and four genes were closely associated with OS. The CPTAC and THPA databases revealed that CHRDL1 and SPARCL1 were downregulated at the mRNA and protein expression levels in LUAD, whereas SPP1 was upregulated. GSEA demonstrated that DNA-dependent DNA replication and catalytic activity acting on RNA were correlated with CHRDL1 and SPARCL1 expression, respectively. The IHC results suggested that CHRDL1 and SPARCL1 were significantly downregulated in LUAD. Conclusions: Our study revealed that survival-related hub genes closely correlated with the initiation and progression of LUAD. Furthermore, CHRDL1 and SPARCL1 are potential therapeutic and prognostic indicators of LUAD. |
WOS关键词 | CANCER ; IDENTIFICATION ; INTEGRATION ; NETWORKS ; PACKAGE ; RICH |
资助项目 | National Natural Science Foundation of China[81672972] ; Zhejiang Provincial Key Research and Development Program[2019C03003] |
WOS研究方向 | Oncology |
语种 | 英语 |
WOS记录号 | WOS:000656240100002 |
出版者 | BMC |
资助机构 | National Natural Science Foundation of China ; Zhejiang Provincial Key Research and Development Program |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/122626] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Chen, Ming |
作者单位 | 1.Chinese Acad Sci, Inst Canc Res & Basic Med IBMC, Hangzhou 310022, Peoples R China 2.Nanchang Univ, Jiangxi Med Coll, Nanchang 331800, Jiangxi, Peoples R China 3.Zhejiang Chinese Med Univ, Hangzhou 310022, Peoples R China 4.Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China 5.Univ Chinese Acad Sci, Dept Radiat Oncol, Canc Hosp, Zhejiang Canc Hosp, Hangzhou 310022, Peoples R China 6.Zhejiang Canc Hosp, Dept Radiat Oncol, Zhejiang Key Lab Radiat Oncol, Hangzhou 310022, Peoples R China |
推荐引用方式 GB/T 7714 | Deng, Huan,Hang, Qingqing,Shen, Dijian,et al. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation[J]. CANCER CELL INTERNATIONAL,2021,21. |
APA | Deng, Huan,Hang, Qingqing,Shen, Dijian,Zhang, Yibi,&Chen, Ming.(2021).Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.CANCER CELL INTERNATIONAL,21. |
MLA | Deng, Huan,et al."Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation".CANCER CELL INTERNATIONAL 21(2021). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。